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Abstract
Objective—To describe the development and implementation of a safer conception service in a 
resource-limited setting.
Methods—Qualitative work to inform the design of a safer conception service was conducted 
with clients and providers at Witkoppen Health and Welfare Centre, a primary health center in 
Johannesburg, South Africa. Services began in July 2013, for HIV-affected participants planning 
conception within six months and included counseling about timed unprotected intercourse and 
home-based self-insemination, early initiation of combined antiretroviral therapy (cART) for HIV-
infected individuals, pre-exposure prophylaxis (PrEP) for HIV-uninfected partners and 
circumcision for men. Participants were enrolled into an implementation science study evaluating 
method uptake, acceptability, and pregnancy and HIV transmission outcomes.
Results—Findings to-date from 51 qualitative participants and 128 clinical cohort participants 
(82 women and 46 men, representing 82 partnerships) are presented. All men were accompanied 
by female partners, whereas 56% of women attended with their male partner. Fifteen of 46 couples 
(33%) were in confirmed serodiscordant relationships, however of the 36 additional women 
attending alone, 56% were unaware of their partners’ HIV status or believed them to be HIV-
uninfected. The majority of HIV-infected women (86%) and men (71%) were on cART at 
enrollment, however only 47% on cART were virally suppressed. Timed unprotected intercourse, 
self-insemination and cART were common choices for participants; few elected PrEP.
Conclusions—Lessons learned from early implementation demonstrate feasibility of safer 
conception services, however reaching discordant couples, cART-naïve infected partners, and men 
remain challenges. Creating demand for safer conception services among those at highest risk for 
HIV transmission is necessary.
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INTRODUCTION
While women and men living with HIV frequently desire to have children [1–6], people 
living with HIV in high burden settings have limited knowledge and communication with 
health care providers regarding safer conception methods [3, 7, 8]. Guidelines for safer 
conception have been published from North American and European countries [9–11] and 
more recently by South Africa [12], but these guidelines have not yet been adopted by 
governments in resource-limited settings or incorporated as standard of care. Consequently, 
couples often try to become pregnant without being informed of how to prevent horizontal 
transmission to partners while trying to conceive and vertical transmission to infants at the 
early stages of conception [3].
Antiretrovirals as prevention could be an important component of safer conception strategies 
[13]. Both combination antiretroviral treatment (cART) and pre-exposure prophylaxis 
(PrEP) can reduce transmission within discordant couples [14, 15], but neither strategy has 
been evaluated in a resource limited setting in the context of safer conception. Those trying 
to conceive are more likely to have increased unprotected sex in order to become pregnant 
and thus evaluation of risk in the context of conception is important. Even among individuals 
with undetectable plasma viral load, virus has been detected in female genital tract and male 
semen samples [16, 17].
Data from 62 discordant couples in Spain and 46 discordant couples in Switzerland have 
demonstrated that cART with or without PrEP can be successfully used for conception in 
[18, 19], but outcomes of treatment as prevention strategies among couples who did not meet 
the viral suppression criteria were not reported. Other methods such as sperm-washing and 
in-vitro fertilization (IVF) or other assisted reproductive techniques have also been used 
successfully to prevent horizontal transmission in serodiscordant couples in Europe and 
other high resource settings [20–22], however these methods are not scalable at a population 
level in a resource-limited setting.
The extent to which safer conception services are being offered in high-burden, resource-
limited settings is unknown, and the outcomes of such services remain unreported [23]. 
Building an evidence base for safer conception strategies will be necessary before services 
can be rolled out across Sub-Saharan African (SSA) countries. In this manuscript, we 
document the development of a safer conception service using an implementation science 
framework and describe the preliminary experiences of this service integrated within a 
primary care clinic in Johannesburg, South Africa.
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After reviewing other implementation science approaches [24–26] and considering elements 
relevant to this research, we developed an implementation science framework with 6 distinct 
phases to guide our safer conception research conducted at the non-governmental, primary 
care clinic, Witkoppen Health and Welfare Centre (WHWC) in Johannesburg, South Africa 
(Figure 1). In phase 1, we reviewed relevant guidelines and literature to collect information 
on possible safer conception strategies [9–12, 14, 15, 27]. In the second phase, we 
performed formative work to assess knowledge about safer conception strategies among 
clinic clients and health care workers, acceptability and preferences for safer conception 
approaches, logistical challenges, and safer conception concerns of patients and health care 
workers. The formative research included four focus group discussions (FGDs) each 
comprised of 6–8 participants (HIV-infected men only, HIV-uninfected men in discordant 
relationships, HIV-infected women only, and HIV uninfected women in discordant 
relationships), sixteen in-depth interviews with clinic clients, again ensuring equal 
representation across gender and HIV-status, and nine key informant interviews with health 
care providers, which included HIV doctors, nurses and lay counselors. In phase 3, we 
designed the safer conception service to be implemented at the clinic based on evidence 
collected in phases 1 and 2. Service delivery at the Sakh’umndeni (“building the family”) 
Safer Conception Clinic and data collection (phase 4) began in July 2013. As part of the first 
iterative evaluation process (phase 5), we performed a descriptive analysis of the 
characteristics of the first 128 individuals receiving safer conception services. We also 
assessed lessons learned from operating the safer conception clinic for nine months. In the 
future (phase 6), we will evaluate uptake, acceptability, comparative effectiveness, feasibility 
and scalability of the services offered to inform final recommendations for an optimized 
package of safer conception care integrated within a primary care clinic in a high burden, 
low resource setting.
Ethics approval for this research was obtained from the University of North Carolina IRB 
and the Human Research Ethics Committee at the University of the Witwatersrand.
RESULTS
Formative research to inform safer conception strategies
Key findings from sixteen in-depth interviews, nine key informant interviews and four FGDs 
are presented in Table 1. In general, availability of safer conception options for couples 
affected by HIV was limited, as highlighted by the story of one male FGD participant.
“My wife she is HIV positive. We asked here if we could have a baby, they said 
yes. We asked how, they said they didn’t know, that we must go to a private clinic. 
It was very expensive. I talked to the doctor – she explained that there was a tablet 
that I could take, but there would be side effects and she couldn’t give it to me, I’d 
have to go somewhere else and also pay for the consultation fees and the tablets. 
She said I could also do sperm insemination in the clinic, but I couldn’t afford it. 
But she said the other option was to use a syringe – by not using a normal process. 
So I went to the pharmacy to get one and they thought I was a drug user so they just 
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gave it to me and told me to leave without paying. So we used the syringe to 
inseminate her after we had sex – and then we had to boil it and sterilize it because 
we only had one. So now she is pregnant.” [Quote is from an HIV-uninfected man, 
in a relationship with an HIV-infected woman.]
When asked by others in the group whether he found the method to be acceptable, the 
participant expressed desperation and ambivalence.
“I did this because I was desperate. I previously broke up with a woman who was 
HIV positive. I wanted to have a kid and we tested and she was positive and I just 
couldn’t do it. Now again, I want to get pregnant and this is the third partner I’ve 
had who is positive, so I just said, maybe I am meant to be with a positive woman, 
just let me stay positive about it and live positively. I know many people who are 
HIV negative who died or are unhappy and many who are positive who are very 
happy and healthy, so let me just accept this…If a pill were available, I would have 
preferred that. Sterilizing after every use was too difficult.”
Knowledge on safer conception for individuals affected by HIV was low and mainly focused 
on prevention of mother-to-child transmission (PMTCT) of HIV. Some participants had 
heard of sperm-washing or in-vitro fertilization, but fewer were aware of home-based self-
insemination methods. There was substantial interest in self-insemination among HIV-
infected women and HIV-uninfected men to eliminate risk for the male uninfected partner. 
Some participants were aware that cART for the infected partner could be used to prevent 
horizontal transmission, yet HIV-infected women believed that men would not take cART 
and endure the side effects if they were not ill, and men had little trust in treatment as 
prevention. None of the women or men identified PrEP for the uninfected partner as a 
prevention method. Perceptions about PrEP were mixed, with participants generally feeling 
that the potential for side effects was a real concern. Condoms for prevention were the 
primary messages received or at least internalized by patients. Particularly among those 
already on cART, 100% condom use was often cited as the only way to ensure HIV 
prevention, thus pitting HIV prevention against reproductive goals.
Among health care workers, HIV clinicians demonstrated sufficient knowledge and reported 
prior experience counseling couples affected by HIV, but indicated that most counseling 
around fertility was client initiated. In contrast, counselors felt they lacked the required 
knowledge to effectively counsel clients and expressed concerns around the window period 
and re-infection. Clinicians also raised concerns regarding the difficulty of achieving 
sustained adherence and viral suppression, the challenge of involvement of the male partners 
in conception issues, and underlying fertility issues that may reduce the likelihood of 
conception in some HIV infected individuals.
The qualitative work also elucidated information concerning service delivery. Both men and 
women expressed a preference for non-integrated services, in part because it was perceived 
that the wait times would be shorter. Clarity and honesty related to risks and benefits of 
services was another key concern raised by participants.
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Safer conception service model for a high-burden, resource limited setting
The WHWC Sakh’umndeni service delivery model (Figure 2) combines behavioral, 
biomedical and structural prevention tools. Key components are behavioral strategies to 
reduce the frequency of HIV exposure while trying to conceive and to increase male 
involvement in pre-conception care, biomedical interventions to reduce the probability of 
HIV transmission when exposure occurs, and structural components such as advertising to 
promote an environment in which clients are comfortable seeking services and training for 
health care workers to guarantee quality of services.
To identify those in need of safer conception services, all WHWC clients are offered HIV 
counseling and testing (HCT), independent of HIV risk or reason for visit, and all women of 
reproductive age are asked about fertility intentions and contraceptive use and screened for 
pregnancy at every visit. Clients not desiring pregnancy and using a contraceptive method 
are referred to family planning services on-site. Providers also initiate discussions around 
safer conception with HIV-uninfected individuals known to be in a discordant relationship 
and HIV-infected individuals with pregnancy intentions. Individuals in need of safer 
conception services are thus identified at the vitals station, HCT program, general outpatient 
department, or the ARV unit and then referred to the safer conception clinic. Based on our 
formative work, we opted for an on-site separate service (Sakh’umndeni) with dedicated 
staff and patient rooms. An appointment system is used to decrease client wait times, and all 
clients receive comprehensive HIV and general care at Sakh’umdeni in order to avoid 
additional wait times and duplication of services. Services are provided by experienced 
professional nurses trained in cART management and HIV counselors with training in safer 
conception counseling.
A basic package of care is delivered to all safer conception clients. This includes full 
repoductive and HIV history of both partners, HIV testing if the status of a partner is 
unknown or negative, CD4 and viral load assessment, screening for sexually transmitted 
diseases, PAP smear for women, and prescription for folic acid. To reduce the frequency of 
unprotected intercourse, all women receive training on menstrual cycle charting and all 
couples are counselled on the use of condoms and offered family planning until viral 
suppression of the HIV infected partner is achieved. Pregnancy testing is conducted monthly 
to prevent unnecessary HIV exposure following succesful conception. After six months of 
attempted conception, couples are referred off-site for infertility assessment in order to 
prevent prolonged periods of unprotected intercourse if conception is unlikely.
Depending on the HIV status of the male and female partner, tailored strategies for 
prevention are discussed. Participants are provided with an array of options, but choose for 
themselves which strategies they would like to pursue. As shown in Figure 2, options 
include self-insemination using plastic syringes, lifelong or short term cART independent of 
CD4 count for the infected partner with viral load monitoring, PrEP for the uninfected 
partner with monthly HIV testing, and referrals to on-site male medical circumcision for 
HIV-uninfected men.
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Following conception HIV-uninfected partners are monitored for seroconversion throughout 
pregnancy and viral loads of pregnant women are monitored. Pregnancy and infant outcomes 
are assessed and women are offered contraception in the post-partum period.
Implementation data and operational experiences
Among the first 128 safer conception participants, 64% were women and 36% were men 
(Table 2). All men were accompanied at some point by their female partners, but only 56% 
of women were accompanied to the safer conception clinic by their male partner, largely due 
to their partners’ work schedules. The 128 participants belonged to 82 different partnerships. 
Fifteen of the 46 couples in which both partners were enrolled (33%) were in confirmed 
serodiscordant relationships. The number of discordant couples may be higher, as of the 
other 36 women attending without their partners, 56% were unsure of their partners’ HIV 
status (n=9) or believed them to be HIV-uninfected (n=11). The majority of HIV-infected 
women (86%) and men (71%) attending the safer concpetion clinic were already on cART at 
time of enrollment - the median time on cART was two years. Overall half of the women 
(50%) and 36% of men were both on cART and virally suppressed at time of the first safer 
conception clinic visit. Median CD4 count at first visit was relatively high, 483 cells/mm3 
[IQR 324–700] among HIV-infected women and 431 cells/mm3 [IQR 298–525] in HIV-
infected men.
Approaches offered at the clinic are not mutually exclusive and participants choose which 
strategy or strategies they want to pursue after receiving safer conception counseling. All 
women were started on folic acid. Half (50%) of participants elected to use timed 
unprotected intercourse as their conception method, while 37% chose self-insemination 
(including 13/52 couples in which the male partner was HIV-infected), and others remained 
undecided at time of the first visit. Seventeen patients were initiated on cART and two 
started PrEP. Twelve men requested referrals for circumcision, including HIV-infected 
patients. Retention of those enrolled is >90%. Readiness to conceive is often several months 
post-enrollment in order to ensure viral suppression in both partners, with a median 
recommendated wait time for attempted conception of 4 months [IQR: 3–4]. To-date 12 
pregnancies and no seroconversions have been observed.
Important challenges have arisen during the early months of implementation. In the first nine 
months, our clinic did not reach as many couples, particularly discordant couples or couples 
with a cART-naïve infected partner as we had anticipated. Additionally, 44% of women 
attending the clinic were not accompanied by their male partners, 25% of which reported 
that they do not know their partners’ HIV status. Adding weekend or evening hours may 
overcome barriers for some men. Efforts to confirm HIV status and laboratory results of 
consenting male partners unable to attend during clinic hours would improve tailored 
counseling messages. Overall, strategies to create demand among individuals likely to 
benefit the most from safer conception services are needed.
DISCUSSION
Despite a clear need for safer conception services, limited services are available in high 
burden settings and virtually no implementation data is available documenting uptake and 
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outcomes of such services in the SSA region. We described an implemenation science 
approach to offering safer conception care in a primary health setting in South Africa. This 
work highlights the need for knowledge and access to counseling around safer conception, 
and demonstrates that services can be feasibly offered. Early challenges, including slow 
enrollment, reinforce the need for optimization, including health education at the community 
level, enhanced marketing of safer conception services, and systematic screening of fertility 
intentions and referrals for eligible candidates by all health care providers if stand alone 
services are going to be effective in their reach and scaleable.
Our formative work indicated that safer conception knowledge among individuals affected 
by HIV mainly focused on PMTCT of HIV, and 100% condom use was often cited as the 
only way to ensure HIV prevention, thus pitting HIV prevention against reproductive goals. 
Some participants had heard of assisted reproductive techniques, but few were aware of low-
cost methods such as self-insemination. After education around self-insemination for 
discordant couples with uninfected male partners, this method was a viewed favorably by 
HIV-infected women with uninfected partners and HIV-uninfected men – those most likely 
to benefit from the methods. Additionally, few individuals in partnerships affected by HIV 
were aware of the possibility of HIV treatment or PrEP as strategies to prevent horizontal 
and vertical transmission while trying to conceive. HIV-infected women believed that men 
would not view early initiation of cART favorably if they were not ill, and men felt reluctant 
to rely on treatment as prevention as their sole safer conception approach.
In response to the request for short clinic wait times, we developed a separate on-site service 
with dedicated staff, used an appointment system, and provided routine HIV care to make 
the safer conception clinic a one-stop service. Despite these efforts, our early experience 
suggests that involving men remains challenging, likely reducing the effectiveness of 
services provided to the unaccompanied women. In addition, our experience to date 
indicates that concordant HIV-infected couples will comprise a large proportion of safer 
conception clients, including many clients already receiving cART. While this is a 
population in whom the benefit of safer conception services may be lower, its value may still 
be substantial as 50% of HIV-infected women and 64% of HIV-infected men were not 
virally suppressed at their first safer conception clinic visit. Evaluating the value of safer 
conception services when both partners are infected to prevent super-infection and vertical 
transmission is thus warranted.
Our initial experience concerning acceptability reiterates findings from our formative work. 
Despite being offered PrEP for prevention, only 2 of 16 uninfected participants to-date have 
elected to use PrEP. Most participants have selected more than one prevention approach and 
none have refused early cART initiation as a prevention strategy, although initiation is 
typically delayed until the first follow-up visit in order to wait for baseline safety bloodwork 
and administration of adherence counseling. Among those on cART, half of participants 
elected timed unprotected intercourse and many others elected to use self-insemination, 
again reinforcing that patients do not entirely trust that cART alone is sufficient for 
prevention purposes, even in situations in which both partners are HIV-infected. 
Additionally, participants frequently chose prevention options that are not recommended, 
such as HIV-infected men desiring medical male circumcision (MMC) and using self-
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insemination. Although uptake of these methods may not result in increased harm, self-
insemination is less efficient as a conception method than natural intercourse and MMC has 
costs associated with it. Furthermore, in serodiscordant relationships in which the male 
partner is HIV infected, MMC could result in risk compensation in situations in which there 
is no corresponding risk reduction benefit, and counselling must clearly emphasize this 
message.
Evaluation of safer conception approaches will not be without challenges. A randomized 
controlled trial comparing cART for the infected partner vs. PrEP for the uninfected partner 
would provide efficacy data but lacks equipoise and would fail to assess the relevance of 
safer conception interventions for concordant HIV-infected couples. We chose an 
implementation science approach to evaluate a cohort of a broad range of individuals who 
are offered a variety of safer conception choices in a real-world operational setting. The bias 
introduced by the observational approach and the need to disentangle the effect of individual 
strategies within the combination prevention packages will neccesitate advanced 
epidemiologic methods and modeling. These limitations notwithstanding, this research 
offers the opportunitiy to assess uptake, feasibility and effectiveness of the methods.
In the era of rapidly expanding Option B and B+ PMTCT programs which treat women with 
cART once they have conceived, preventing horizontal transmission to partners and ensuring 
viral suppression prior to conception has the potential to further optimize outcomes for the 
mother, father and the future infant. Improved health outcomes and survival of parents will 
also help to improve child health outcomes [28]. Given the importance of reproduction, safer 
conception services should be seen as a necessary component of HIV prevention programs, 
rather than a luxury service. Creating demand for and knowledge of safer conception 
services among the population at highest risk of vertical and horizontal transmission will 
however require careful planning. These data show early promise that these services will be 
feasible, however analyses of the eventual outcome data from this cohort and others, 
including cost-effectiveness analyses, will be necessary to determine how to optimize use of 
resources and at what level scalability is warranted.
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Table 1
Summary of key findings from formative work to design safer conception services
Topics General Themes Expressed by Patients (n=42)





• High knowledge about ARV for prevention of 
mother-to-child transmission of HIV, but low 
recognition that the ARVs could be used to prevent 
transmission in couples
• No knowledge of pre-exposure prophylaxis (PrEP)
• Few had heard of self-insemination methods
• In-vitro fertilizaton was a commonly mentioned 
safer conception method.
• Sperm washing and adoption also identified as 
strategies
• Despite some awareness, little knowledge or 
trust in the concept of HIV treatment as 
prevention.
• Condoms cited as the sole form of protection
• No knowledge of PrEP
• One participant had knowledge of self-
insemination methods and had succuessfully 





• Women (both F+/M- and F-/M+) believed men 
would not take ARVs and endure the side effects if 
they are not sick.
• HIV infected women (F+/M-) preferred using a 
syringe and self-insemination versus PrEP for their 
partners. General perception that self-insemination 
with a syringe would be acceptable to their male 
partners
• HIV uninfected women (F-/M+ or U) did not 
believe that an uninfected partner would agree to 
self-insemination if the female partner were 
infected and the male partner uninfected, but that 
men would be more likely to use PrEP for 
prevention
• HIV-infected men (M+/F +,- or U) expressed 
many concerns over self-insemination.
• HIV-infected men (M+/F-) agreed that PrEP 
for their uninfected partner would be a good 
option and side effects from ARVs could be 
tolerated in the short-term
• HIV-uninfected men (M-/F+) were intrigued by 
the idea of using a syringe for self-





• Doctors and nurses were acceptable providers
• HIV counselors were also recognized as playing a 
vital role.
• Access to gynecologists was highlighted as a need
• Doctors and nurses were acceptable to men
• All participants consistently highlighted the 
importance of HIV counselors in order to 







• Desired a separate space in the clinic for services
• No long queues / use of an appointment system
• Weekends desirable if partners are to accompanry
• No stock-outs
• Clinic must be honest about risk and not promise 
what it cannot deliver
• No queues / use of an appointment system
• Staff should be non-judgmental, confidential, 
professional and kind
• Overall men preferred a separate space for 
services, but responses around integration into 
routine care varied more among men than 
women
General Themes Expressed by Health Care Workers (n=9)





• Patients ask questions about conception, but 
counselors often feel they do not have adequate 
advice aside from the importance of an 
undetectable viral load and referring patients for 
sperm washing if the man is HIV infected
• All had experience with safer conception 
counseling and reported advising on PrEP, 
timed unprotected intercourse and self-
insemination.





• High viral load
• High viral load
• Poor adherence to HAART and PrEP
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Topics General Themes Expressed by Patients (n=42)
Women (n=21) Men (n=21)
• Attempted conception when one partner is in the 
window period
• Reinfection
• Poor knowledge of treatment as prevention due 
to ‘condom only’ messaging
• Partners do not test and/or unwilling to come in
• Low patient knowledge about fertility/
conception
• Underlying (in)fertility issues
F+: HIV-infected female; F-: HIV-uninfected female; M+: HIV-infected male; M-: HIV-uninfected male; U: Unknown HIV status
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Table 2





Age, median years [IQR] 33 [28–38] 38 [34–43]
Currently employed, % 73% 87%
Number of living children, median [IQR] 1 [0–1] 1 [1–2]
Number of children with current partner, median [IQR] 0 [0–1] 0 [0–1]
STI symptoms present at baseline screening, % 1% 0%
Known to be HIV infected at time of enrollment, % 93% 78%
  On HAART, % HIV+ 86% 71%
  Time on HAART, median years [IQR] 2 [1–3] 2 [0–3]
  CD4 cell count, %
    <200 cells/mm3 5% 3%
    200–350 cells/mm3 21% 19%
    351–500 cells/mm3 23% 22%
    >500 cells/mm3 51% 56%
  Viral load, %
    Below the detectable limit (<50 copies/ml) 63% 34%
    50 – 400 copies/ml 22% 29%
    >400 – 10,000 13% 21%
    >10,000 – 50,0000 copies/ml 0% 8%
    >50,000 copies/ml 2% 8%
Circumcised / male partner circumcised, % 48% 36%
Accompanied by partner to safer conception clinic, % 56% 100%
Partner’s HIV Status
Partner known to be HIV-infected at enrollment, % 57% 80%
  Partner on HAART at enrollment, % of known HIV+ 68% 84%
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